Need assistance?
At a glance
- Better mental health outcomes: People taking GLP-1 medications such as semaglutide experienced lower rates of depression, anxiety, and psychiatric hospital care.
- Benefits beyond diabetes and weight loss: The drugs were also linked to fewer substance use problems, reduced sickness absence, and a lower risk of suicidal behaviour.
- Promising but not yet conclusive: While the findings suggest GLP-1 medications may support mental health, more research is needed to understand how and why these effects occur.
A large study of nearly 100,000 people suggests that medications commonly used to treat type 2 diabetes and obesity may also be associated with lower rates of depression, anxiety, substance use problems, and psychiatric hospital care.
Medications such as Ozempic and Wegovy have become widely known for their role in managing diabetes and supporting weight loss. However, new research published in The Lancet Psychiatry suggests these drugs may also be linked to improvements in mental health.
Researchers from the University of Eastern Finland, Karolinska Institutet, and Griffith University found that people taking GLP-1 receptor agonists experienced fewer psychiatric hospital visits and less time off work due to mental health conditions.
Tracking Mental Health Outcomes Over Time
To investigate the relationship, researchers analysed data from Swedish national health registers, following nearly 100,000 people between 2009 and 2022. More than 20,000 participants had used GLP-1 medications during that period.
The study compared individuals’ mental health outcomes during periods when they were taking the medication with periods when they were not. This allowed the researchers to examine whether the use of GLP-1 drugs was associated with changes in psychiatric health over time.
Fewer Cases of Depression, Anxiety, and Psychiatric Care
The researchers found that GLP-1 medications, particularly semaglutide, the active ingredient in Ozempic and Wegovy, were linked to significantly better mental health outcomes.
During periods of semaglutide use, psychiatric hospital care and sickness absence related to mental health were 42% lower than during periods when individuals were not taking the medication. Depression risk was 44% lower, while anxiety disorders were reduced by 38%.
The study also found that hospital care and sickness absence related to substance use disorders were 47% lower during periods of semaglutide use. In addition, GLP-1 receptor agonists were associated with a lower risk of suicidal behaviour.
Commenting on these findings, Professor Mark Taylor from Griffith University said:
“An earlier study examining Swedish registers found the use of GLP-1 medications to be associated with a reduced risk of alcohol use disorder. Alcohol-related problems often have downstream effects on mood and anxiety, so we expected the effect to be positive on these as well.”
Why Might These Drugs Affect Mental Health?
The researchers say it is still unclear why these medications may be linked to improved mental health. Because the study was observational and based on health records, it cannot determine whether the drugs directly caused these changes.
Research Director and study author Markku Lähteenvuo said:
“Because this is a registry-based study, we cannot determine exactly why or how these medications affect mood symptoms, but the association was quite strong.”
He added that several factors may be involved, including reduced alcohol consumption, improvements in body image following weight loss, better diabetes management, or direct effects on the brain’s reward system.
More Research Is Still Needed
Previous studies examining GLP-1 medications and mental health have produced mixed findings, although many were smaller in scale. By following people over a longer period and using a much larger sample, this study provides stronger evidence that these medications could have effects beyond blood sugar control and weight management.
However, the researchers emphasise that more work is needed to understand the biological mechanisms involved and to determine whether the relationship is causal. The findings highlight an important area for future research into the links between physical and mental health.
How You Can Support Us
Donate
Donate towards the improvement and prevention of mental illness.
Fundraise
Raise money for mental health research by organising a fundraising event.
Subscribe
Keep up with latest updates in the world of mental health research.
The post Could Weight Loss Drugs Also Benefit Mental Health? first appeared on MQ Mental Health Research.
Source link
Advertisement
